Resistance to cetuximab – implication of PTEN expression in the cellular sensitivity to cetuximab (Erbitux®) of Head and Neck Squamous Cell Carcinoma (HNSCC) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue EJC Supplements Année : 2008

Resistance to cetuximab – implication of PTEN expression in the cellular sensitivity to cetuximab (Erbitux®) of Head and Neck Squamous Cell Carcinoma (HNSCC)

Dates et versions

hal-03710282 , version 1 (30-06-2022)

Identifiants

Citer

J. Mriouah, C. Chartier, C. Boura, A. Fifre, Isabelle Fries, et al.. Resistance to cetuximab – implication of PTEN expression in the cellular sensitivity to cetuximab (Erbitux®) of Head and Neck Squamous Cell Carcinoma (HNSCC). EJC Supplements, 2008, 6 (9), pp.112. ⟨10.1016/S1359-6349(08)71601-X⟩. ⟨hal-03710282⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More